Rearrangement of the ROS1 gene is observed in ~1–2% of patients NSCLC [158–161], particularly in non-smokers, those with lung adenocarcinomas, and patients without alterations in the EGFR or ALK genes [159, 160, 162]. The gene discussed is ALK; the disease is lung adenocarcinoma.